Adolescent Consent & Sexual Violence: A School Intervention Evaluation
Launched by UPPSALA UNIVERSITY · Nov 9, 2023
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background: Young people and LGBTQ+ people are currently, and have long been, over-represented as victims of sexual offences in Sweden. This is clearly illustrated in both statistics from the Swedish National Council for Crime Prevention and in the scientific literature. In order to counteract and prevent violence among young people and boys' violence against girls, the government has created a specific action programme that particularly emphasises preventive measures with the aim of improving knowledge and developing methods. The action programme emphasises the role of schools in working t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages between 15-18 y/o
- • Participant goes to a school that is part of the study
- Exclusion Criteria:
- • Person is under the age of 15 y/o or over the age of 18 y/o
- • Person is not enrolled in one of the schools who are part of the study
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
Anna Sarkadi, Professor
Principal Investigator
Uppsala University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported